ReviewSafety and health at work2026
Workplace HIV and TB Programmes for Laboratory Health Workers: A Rapid Review.
Review in Safety and health at work, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human immunodeficiency virus (HIV) and tuberculosis (TB) remain global health challenges. Health workers (HWs), particularly laboratory HWs who handle infectious samples, face increased occupational risks of infection. Laboratory HWs are essential for disease diagnosis and monitoring, yet their health is endangered by workplace exposures to HIV and TB, potentially leading to workforce depletion and compromised healthcare delivery. Despite existing guidelines and policies for access and implementation of effective occupational health services (OHS), including hazard identification, medical surveillance, and postexposure preventive treatment, these are often obstructed by resource limitations. Objective: This review paper discusses the morbidity of HIV and TB among laboratory HWs, and explores the enablers and barriers to accessing HIV and TB OHS. Methods: A literature search was conducted using the EBSCOhost databases. Relevant keywords identified studies related to HWs, specifically laboratory HWs. Eligible studies were organised using a flow diagram, resulting in 13 papers. Data concerning morbidity, enabling factors, barriers, and recommendations were extracted using a modified tool. Results: Studies consistently demonstrate a high prevalence of latent TB Infection and active TB among laboratory HWs handling mycobacteria. Barriers to accessing OHS are more frequently reported than enablers, and HIV data specific to laboratory HWs were limited. Recommended interventions include enhanced surveillance, stronger OHS programmes, and integrating OHS and infection control. Conclusion: Despite growing evidence, gaps remain in implementation, and further studies are needed to assess the real-world application of recommended measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.